-- 惠譽評級在近期發布的報告中指出,印尼擬議的礦業政策改革對煤礦商、礦業承包商和下游鎳加工商的影響將各不相同。 惠譽表示,煤炭政策提案可能會對煤礦商和承包商的現金流造成不利影響,而鎳價波動則可能對加工商造成壓力。 惠譽指出,擬議的出口關稅將縮小實際利潤率,而降低的產量配額將對上游生產商的產量和現金流造成壓力。 該評級機構表示,減少剝離和表土移除將對礦業承包商產生連鎖反應。 惠譽表示,這些提案已經對礦業活動產生了影響,由於產量下降和現貨銷售暫停,印尼2026年前兩個月的煤炭出口量比去年同期下降了7%。 惠譽認為,印尼與礦業相關的風險正在增加,持續的政策不確定性可能導致該國風險評估降低,並對煤礦商的信用狀況構成負面壓力。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.